V. Wayne Engleman

789 total citations
9 papers, 539 citations indexed

About

V. Wayne Engleman is a scholar working on Immunology and Allergy, Hematology and Molecular Biology. According to data from OpenAlex, V. Wayne Engleman has authored 9 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology and Allergy, 4 papers in Hematology and 3 papers in Molecular Biology. Recurrent topics in V. Wayne Engleman's work include Cell Adhesion Molecules Research (7 papers), Platelet Disorders and Treatments (4 papers) and Bone Metabolism and Diseases (2 papers). V. Wayne Engleman is often cited by papers focused on Cell Adhesion Molecules Research (7 papers), Platelet Disorders and Treatments (4 papers) and Bone Metabolism and Diseases (2 papers). V. Wayne Engleman collaborates with scholars based in United States, Australia and United Kingdom. V. Wayne Engleman's co-authors include G. Allen Nickols, Steven L. Settle, M. A. Horton, David W. Griggs, Steven L. Teitelbaum, F. Patrick Ross, Peter Ruminski, Stephen R. Rapp, Albert Derby and Gabrielle R. Neises and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Endocrinology.

In The Last Decade

V. Wayne Engleman

9 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Wayne Engleman United States 7 262 204 173 117 89 9 539
Nijole Gasiunas United Kingdom 9 495 1.9× 53 0.3× 120 0.7× 129 1.1× 45 0.5× 12 703
Hiroya Takami Japan 11 369 1.4× 168 0.8× 71 0.4× 31 0.3× 17 0.2× 16 724
Judith Sudhalter United States 5 369 1.4× 128 0.6× 119 0.7× 27 0.2× 76 0.9× 5 609
P Rossino Italy 11 318 1.2× 375 1.8× 80 0.5× 96 0.8× 52 0.6× 16 724
Gunay Cizmeci-Smith United States 10 387 1.5× 217 1.1× 25 0.1× 46 0.4× 35 0.4× 10 730
Rachel Bar‐Shavit Israel 10 331 1.3× 116 0.6× 94 0.5× 24 0.2× 218 2.4× 12 697
Elizabeth M. Chislock United States 6 248 0.9× 60 0.3× 197 1.1× 13 0.1× 67 0.8× 6 469
Laura Dupont Belgium 12 151 0.6× 53 0.3× 155 0.9× 27 0.2× 36 0.4× 14 427
Bent Winding Denmark 15 348 1.3× 47 0.2× 341 2.0× 29 0.2× 308 3.5× 26 895
Shelley N.-M. Thai United States 8 279 1.1× 141 0.7× 106 0.6× 27 0.2× 100 1.1× 8 598

Countries citing papers authored by V. Wayne Engleman

Since Specialization
Citations

This map shows the geographic impact of V. Wayne Engleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Wayne Engleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Wayne Engleman more than expected).

Fields of papers citing papers by V. Wayne Engleman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Wayne Engleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Wayne Engleman. The network helps show where V. Wayne Engleman may publish in the future.

Co-authorship network of co-authors of V. Wayne Engleman

This figure shows the co-authorship network connecting the top 25 collaborators of V. Wayne Engleman. A scholar is included among the top collaborators of V. Wayne Engleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Wayne Engleman. V. Wayne Engleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Nagarajan, Srinivasan, et al.. (2006). Discovery of Diphenylmethanepropionic and Dihydrostilbeneacetic Acids as Antagonists of the Integrin αvβ3. Chemical Biology & Drug Design. 67(2). 177–181. 4 indexed citations
2.
Penning, Thomas D., Mark A. Russell, Helen Y. Chen, et al.. (2004). Synthesis of cinnamic acids and related isosteres as potent and selective αvβ3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(6). 1471–1476. 14 indexed citations
3.
Engleman, V. Wayne, et al.. (2000). Peptidomimetic antagonists of alphavbeta3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone. Journal of Endocrinology. 165(3). 587–598. 46 indexed citations
4.
Engleman, V. Wayne, G. Allen Nickols, F. Patrick Ross, et al.. (1997). A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.. Journal of Clinical Investigation. 99(9). 2284–2292. 228 indexed citations
5.
Engleman, V. Wayne, Steven L. Settle, Richard Ornberg, et al.. (1996). Antibody to beta3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat.. Endocrinology. 137(3). 918–924. 60 indexed citations
6.
Panzer‐Knodle, Susan G., et al.. (1995). Characterization of Binding of an RGD Mimetic, [3H]-SC-52012, to Platelet GPIIb/IIIa. Platelets. 6(5). 288–295. 1 indexed citations
7.
Nicholson, Nancy S., Susan G. Panzer‐Knodle, Anita K. Salyers, et al.. (1995). SC-54684A: An Orally Active Inhibitor of Platelet Aggregation. Circulation. 91(2). 403–410. 56 indexed citations
8.
Nicholson, Nancy S., Susan G. Panzer‐Knodle, F. S. TJOENG, et al.. (1994). SC-49992-A potent and specific inhibitor of platelet aggregation. Thrombosis Research. 74(5). 523–535. 11 indexed citations
9.
Derby, Albert, V. Wayne Engleman, Gregory E. Frierdich, et al.. (1993). Nerve Growth Factor Facilitates Regeneration across Nerve Gaps: Morphological and Behavioral Studies in Rat Sciatic Nerve. Experimental Neurology. 119(2). 176–191. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026